Catalyst Wire Dossier Catalyst Wire Dossier

Lansoprazole Intravenous 30 mg

lansoprazole · Takeda
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lansoprazole Intravenous 30 mg, covering 2016-02-23 to 2016-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]

See pricing